Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021:1318:469-483.
doi: 10.1007/978-3-030-63761-3_27.

Ventilatory Support in Patients with COVID-19

Affiliations

Ventilatory Support in Patients with COVID-19

Paolo Maria Leone et al. Adv Exp Med Biol. 2021.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the novel coronavirus disease 2019 (COVID-19) pandemic, which spread throughout the world. Acute hypoxemic respiratory failure is the most dangerous complication of COVID-19 pneumonia. To date, no specific therapeutic drugs or vaccines have been proven efficacious. Ventilatory support is still a significant challenge for physicians facing COVID-19. The mechanisms underlying hypoxemia in those patients are not fully understood, but a new physiopathology model has been proposed. Oxygen therapy should be delivered to patients with mild to moderate hypoxemia. More severe patients could benefit from other treatments (high-flow nasal cannula, noninvasive ventilation or intubation, and invasive ventilation). Given the rapid evolution of COVID-19, there has been a paucity of the high-quality data that typically inform clinical practice guidelines from professional societies, and a worldwide consensus is still lacking. This chapter aims to illustrate the potentials of ventilatory support as therapeutic options for adult and pediatric patients affected by COVID-19 pneumonia.

Keywords: ARDS; Acute respiratory failure; COVID-19; Guidelines; HFNC; Mechanical ventilation; Oxygen therapy; Pediatric.

PubMed Disclaimer

References

    1. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A (2020) Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 46(5):854–887. https://doi.org/10.1007/s00134-020-06022-5 - DOI - PubMed
    1. Antonelli M, Conti G, Esquinas A, Montini L, Maggiore SM, Bello G, Rocco M, Maviglia R, Pennisi MA, Gonzalez-Diaz G, Meduri GU (2007) A multiple-center survey on the use in clinical practice of non-invasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med 35(1):18–25. https://doi.org/10.1097/01.CCM.0000251821.44259.F3 - DOI - PubMed
    1. Archer SL, Sharp WW, Weir EK (2020) Differentiating COVID-19 pneumonia from acute respiratory distress syndrome (ARDS) and high altitude pulmonary edema (HAPE): therapeutic implications. Circulation 142:101. CIRCULATIONAHA.120.047915. https://doi.org/10.1161/CIRCULATIONAHA.120.047915 - DOI - PubMed - PMC
    1. Barrot L, Asfar P, Mauny F, Winiszewski H, Montini F, Badie J, Quenot J-P, Pili-Floury S, Bouhemad B, Louis G, Souweine B, Collange O, Pottecher J, Levy B, Puyraveau M, Vettoretti L, Constantin J-M, Capellier G (2020) Liberal or conservative oxygen therapy for acute respiratory distress syndrome. N Engl J Med 382(11):999–1008. https://doi.org/10.1056/NEJMoa1916431 - DOI - PubMed
    1. Beloncle FM, Pavlovsky B, Desprez C, Fage N, Olivier P-Y, Asfar P, Richard J-C, Mercat A (2020) Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome. Ann Intensive Care 10(1):55. https://doi.org/10.1186/s13613-020-00675-7 - DOI - PubMed - PMC

LinkOut - more resources